Nanjing Medlander Medical Technology Co (SHSE:688273) Capital Expenditure : ¥-119.81 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Nanjing Medlander Medical Technology Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Nanjing Medlander Medical Technology Co's cash flow for capital expenditures for the three months ended in Mar. 2024 was ¥-49.3 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-119.81 Mil.

Nanjing Medlander Medical Technology Co Capital Expenditure Historical Data

The historical data trend for Nanjing Medlander Medical Technology Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Medlander Medical Technology Co Capital Expenditure Chart

Nanjing Medlander Medical Technology Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Capital Expenditure

Get a 7-Day Free Trial

-45.68

-25.91

-14.59

-54.26

-75.15

Nanjing Medlander Medical Technology Co Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Capital Expenditure	Get a 7-Day Free Trial												-4.64	-27.78	-9.60	-33.13	-49.30

Nanjing Medlander Medical Technology Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-119.81 Mil.

Nanjing Medlander Medical Technology Co (SHSE:688273) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanjing Medlander Medical Technology Co Ltd (SHSE:688273) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 2, Gande Road, 2nd Floor, Building 5, Jiangning High-tech Park, Jiangning District, Jiangsu Province, Nanjing City, CHN, 211100

Website

http://www.medlander.com

Nanjing Medlander Medical Technology Co Ltd is engaged in the research and development, production, sales and service of related products in the field of pelvic floor and postpartum rehabilitation.

Executives

Zhu Bi Sheng	senior management
Chen Jiang Ning	senior management
Yang Rui Jia	Directors, senior managers, core technical personn
Shi Zhi Huai	Directors, senior managers, core technical personn
Chen Bin	Directors, senior managers
Tu Hong Lin	Directors, senior managers
Wang Wang	senior management

Nanjing Medlander Medical Technology Co (SHSE:688273) Headlines

No Headlines